No Data
Cipher Pharmaceuticals Announced Normal Course Issuer Bid, Including Intention to Utilize Block Purchases
Cipher Pharmaceuticals Secures Medicaid Preferred Status for Natroba in Illinois
Cipher Pharmaceuticals Brief: Says Secured Medicaid Step-Through Preferred Status for Natroba in the State of Illinois
Neupath Health Appoints Stephen Lemieux as President
Cipher Pharmaceuticals Inc. Price Target Announced at C$12.50/Share by Canaccord Genuity
Earnings Call Summary | Cipher Pharmaceuticals Inc(CPHRF.US) Q4 2024 Earnings Conference